510(k) · Cleared
ClearedContour SE Microspheres
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Boston Scientific Corp · KRD Device, Vascular, For Promoting Embolization
Cleared on Mar 26, 2004 as substantially equivalent to K022427 (Boston Scientific Corp, 2002) and 3 other predicates after an 86-day review. Its family tree reaches back 5 generations to 1996. 10 later devices descend from it.
- Decided
- Mar 26, 2004
- Review
- 86 days
- Class
- Class II
- Product code
- KRD
- Recalls
- None
- Predicates
- 4
Its longest line of descent runs back 5 generations to K961923 (1996). 11 ancestors in all, the oldest K871047 (1987). 10 later devices descend from it, 3 citing it directly.
- Root · 5 generations backK961923 Berenstein CoilTarget Therapeutics · 1996
- 4 generations backK964112 Berenstein CoilTarget Therapeutics · 1997
- 3 generations backK991549 Embosphere MicrospheresBiosphere Medical · 2000
- 2 generations backK021397 Embosphere Microspheres and Embogold Microspheres for Use in Uterine…Biosphere Medical, Inc. · 2002
- 1 generation backK030966 Contour Emboli Pva and Fastracker-325 Infusion CatheterBoston Scientific Corp · 2003 · Recalled
- This deviceK034068 Contour SE MicrospheresBoston Scientific Corp · 2004
- Descendant · cites it directly · 6 of its ownK073417 Embozene MicrospheresCelonova Biosciences, Inc. · 2008
- Descendant · 2 generations on · 4 of its ownK132675 Embozene MicrospheresCelonova Biosciences, Inc. · 2013
- Descendant · 2 generations on · 2 of its ownK133447 Embozene Color-Advanced Microspheres, Embozene Opaque (Non-Colored)…Celonova Biosciences, Inc. · 2014
- Descendant · 2 generations on · 2 of its ownK130307 Oncozene Microspheres 40UM, 2ML, Oncozene Microspheres 75UM, 2ML…Celonova Biosciences, Inc. · 2013
- Descendant · 2 generations on · 1 of its ownK141209 Embozene Color-Advanced Microspheres, Embozene Opaque (Non-Colored)…Celonova Biosciences, Inc. · 2014
Showing 5 of 10 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 10 · See all- K073417Embozene MicrospheresCelonova Biosciences, Inc. · 2008 · cites it directly6descendants
- K132675Embozene MicrospheresCelonova Biosciences, Inc. · 2013 · 2 generations on4descendants
- K133447Embozene Color-Advanced Microspheres, Embozene Opaque (Non-Colored) MicrospheresCelonova Biosciences, Inc. · 2014 · 2 generations on2descendants
- K130307Oncozene Microspheres 40UM, 2ML, Oncozene Microspheres 75UM, 2ML, Oncozene Microspheres…Celonova Biosciences, Inc. · 2013 · 2 generations on2descendants
- K141209Embozene Color-Advanced Microspheres, Embozene Opaque (Non-Colored) Microspheres…Celonova Biosciences, Inc. · 2014 · 2 generations on1descendant
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −5 | K961923 | Berenstein Coil | Target Therapeutics | 1996 | — |
| −4 | K964112 | Berenstein Coil | Target Therapeutics | 1997 | — |
| −3 | K991549 | Embosphere Microspheres | Biosphere Medical | 2000 | — |
| −2 | K021397 | Embosphere Microspheres and Embogold Microspheres for Use in Uterine Fibroid… | Biosphere Medical, Inc. | 2002 | — |
| −1 | K030966 | Contour Emboli Pva and Fastracker-325 Infusion Catheter | Boston Scientific Corp | 2003 | 1 |
| 0 (this device) | K034068 | Contour SE Microspheres | Boston Scientific Corp | 2004 | — |
| +1 | K073417 | Embozene Microspheres | Celonova Biosciences, Inc. | 2008 | — |
| +2 | K132675 | Embozene Microspheres | Celonova Biosciences, Inc. | 2013 | — |
| +2 | K133447 | Embozene Color-Advanced Microspheres, Embozene Opaque (Non-Colored) Microspheres | Celonova Biosciences, Inc. | 2014 | — |
| +2 | K130307 | Oncozene Microspheres 40UM, 2ML, Oncozene Microspheres 75UM, 2ML, Oncozene… | Celonova Biosciences, Inc. | 2013 | — |
| +2 | K141209 | Embozene Color-Advanced Microspheres, Embozene Opaque (Non-Colored)… | Celonova Biosciences, Inc. | 2014 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1987 | 1 | 0 |
| 1994 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 2 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2006 | 1 | 0 |
| 2008 | 3 | 0 |
| 2013 | 2 | 0 |
| 2014 | 2 | 0 |
| 2016 | 1 | 0 |
| 2024 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in KRD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new KRD device
- #1 K253511 Concerto Versa™ Detachable Coilscore 17.6 · 14 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (4)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K022427 | Contour SE MicrospheresSummary page 1…me: Contour SETM Microspheres Provisions Classification Name: Artificial Embolization Device Name of Contour SETM Microspheres (K022427, K032707 & K032542) Predicate Contour TM Emboli PVA (K030966) Devices Classification Class III Perform… | 2002 |
| * | K032707 | Contour SE Microspheres (Syringe)Summary page 1…ur SETM Microspheres Provisions Classification Name: Artificial Embolization Device Name of Contour SETM Microspheres (K022427, K032707 & K032542) Predicate Contour TM Emboli PVA (K030966) Devices Classification Class III Performance… | 2003 |
| * | K032542 | Modification to Contour SE MicrospheresSummary page 1…crospheres Provisions Classification Name: Artificial Embolization Device Name of Contour SETM Microspheres (K022427, K032707 & K032542) Predicate Contour TM Emboli PVA (K030966) Devices Classification Class III Performance Pe… | 2003 |
| * | K030966 | Contour Emboli Pva and Fastracker-325 Infusion CatheterSummary page 1…tion Name: Artificial Embolization Device Name of Contour SETM Microspheres (K022427, K032707 & K032542) Predicate Contour TM Emboli PVA (K030966) Devices Classification Class III Performance Performance Standards have not been established by FDA und… | 2003 |
What descends from it? (10)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 8 years and passes through 4 companies; a new generation was cleared every 10 months on median.
- 1 of the 11 ancestors has a recall of any class.
- Of its descendants, K073417 (Celonova Biosciences, Inc., 2008) has gone furthest, with 6 descendants of its own.
- 1 other device also cites its predicate K022427.
How does its category compare?
All KRD devicesKRD Device, Vascular, For Promoting Embolization: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · KRD
9in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · KRD
60in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · KRD
1in 2024
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · KRD
1,572in 2025
MAUDE reports naming product code KRD, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 21 |
| 2008 | 5 | 84 | 0 | 14 |
| 2009 | 4 | 27 | 0 | 40 |
| 2010 | 3 | 150 | 1 | 61 |
| 2011 | 5 | 36 | 0 | 102 |
| 2012 | 8 | 30 | 0 | 137 |
| 2013 | 11 | 33 | 1 | 244 |
| 2014 | 7 | 134 | 0 | 159 |
| 2015 | 11 | 130 | 0 | 337 |
| 2016 | 4 | 164 | 0 | 437 |
| 2017 | 4 | 89 | 0 | 736 |
| 2018 | 4 | 62 | 0 | 1,066 |
| 2019 | 6 | 178 | 0 | 1,185 |
| 2020 | 4 | 137 | 0 | 1,167 |
| 2021 | 3 | 134 | 0 | 1,444 |
| 2022 | 8 | 175 | 0 | 1,498 |
| 2023 | 2 | — | 1 | 1,371 |
| 2024 | 6 | 70 | 1 | 1,535 |
| 2025 | 9 | 60 | 0 | 1,572 |
| 2026 | 7 | 70 | 1 | — |
What is it indicated for?
Contour SETM Microspheres may be used for the embolization of hypervascular tumors, including leiomyoma uteri, and arteriovenous malformations (AVMs).
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K034068 · printed Nov 5, 2026
Cite this page
510(k) Report. “K034068: Contour SE Microspheres.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K034068
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026